Scott Gottlieb, former FDA commissioner, joins “Closing Bell” to discuss a potential second wave of coronavirus cases.

U.S. drugmaker Merck on Tuesday said it plans to work alongside IAVI, a non-profit scientific research organization, to develop a potential vaccine against the coronavirus. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss.

A draft government report obtained by the New York Times says Covid-19 deaths could reach 3,000 a day by June 1. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss.

Controversy over a leaked Gilead Sciences document that stated studies of its hopeful coronavirus treatment, Remdesivir, have proven inconclusive. Gilead has come out saying the document contained inappropriate characterization blaming some of the issues on low enrollment in the study. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss.

Reports that Gilead’s drug Remdesivir is reportedly showing effectiveness in treating coronavirus sent the stock higher ahead of Friday’s open. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss.

Dr. Scott Gottlieb, former FDA commissioner, joins CNBC’s special coverage of the coronavirus pandemic to discuss that there could be a promising treatment as soon as this summer.